Blood concentrations are better predictors of chioroquine poisoning severity than plasma concentrations: a prospective study with modeling of the concentration/effect relationships

References

• Guillion C, Le Bonniec Y. Suicide mode d'emploi. Histoire, technique, actualité. Paris: Alan Moreau Editions; 1982.
   Google Scholar
• Ball DE, Tagwireyi D, Nhachi CF. Chloroquine poisoning in Zimbabwe: a toxicoepidemiological study. J Appl Toxicol 2002; 22:311–315.
   PubMed Web of Science ®Google Scholar
• Riou B, Barriot P, Rimailho A, Baud FJ. Treatment of severe chloroquine poisoning. N Engl J Med 1988; 318:1–6.
   PubMed Web of Science ®Google Scholar
• Clemessy JL, Taboulet P, Hoffman JR, Hantson P, Barriot P, Bismuth C, Baud FJ. Treatment of acute chloroquine poisoning: a 5 years experience. Crit Care Med 1996; 24:1189–1195.
   PubMed Web of Science ®Google Scholar
• Hojer J, Malmlund HO, Berg A. Clinical features in 28 consecutive cases of laboratory confirmed massive poisoning with carbamazepine alone. J Toxicol Clin Toxicol 1993; 31:449–458.
   PubMed Web of Science ®Google Scholar
• Apfelbaum JD, Caravati EM, Kerns WP II, Bossart PJ, Larsen G. Cardiovascular effects of carbamazepine toxicity. Ann Emerg Med 1995; 25:631–635.
   PubMed Web of Science ®Google Scholar
• Boehnert MT, Lovejoy FH Jr. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med 1985; 313:474–479.
   PubMed Web of Science ®Google Scholar
• Mégarbane B, Leprince P, Deye N, Résière D, Guerrier G, Rettab S, Théodore J, Karyo S, Gandjbakhch I, Baud FJ. Emergency feasibility in medical intensive care unit of extracorporeal life support for refractory cardiac arrest. Intensive Care Med 2007; 33:758–764.
   PubMed Web of Science ®Google Scholar
• Piotrovsky V. Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation. AAPS J 2005; 7:E609–E624.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute Dialysis Quality Initiative workgroup: Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204–R212.
   PubMed Web of Science ®Google Scholar
• Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818–824.
   PubMed Web of Science ®Google Scholar
• Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957–2963.
   PubMed Web of Science ®Google Scholar
• Monnet R, Boiteau H, Moussion C. Identification and determination of chloroquine in biological media by ultraviolet spectrophotometry. Ann Biol Clin (Paris) 1964; 22:429–434.
   PubMedGoogle Scholar
• Rombo L, Ericsson O, Alván G, Lindström B, Gustafsson LL, Sjöqvist F. Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples. Ther Drug Monit 1985; 7:211–215.
   PubMed Web of Science ®Google Scholar
• Houzé P, de Reynies A, Baud FJ, Benatar MF, Pays M. Simultaneous determination of chloroquine and its three metabolites in human plasma, whole blood and urine by ion-pair high-performance liquid chromatography. J Chromatogr 1992; 574:305–312.
   PubMed Web of Science ®Google Scholar
• Ducharme J, Farinotti R. Rapid and simple method to determine chloroquine and its desethylated metabolites in human microsomes by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl 1997; 698:243–250.
   PubMed Web of Science ®Google Scholar
• Verdier F, Le Bras J, Clavier F, Hatin I. Blood levels and in vitro activity of desethylchloroquine against Plasmodium falciparum. Lancet 1984; 1:1186–1187.
   PubMed Web of Science ®Google Scholar
• Friberg LE, Isbister GK, Duffull SB. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. Br J Clin Pharmacol 2006; 61:177–190.
   PubMed Web of Science ®Google Scholar
• Friberg LE, Isbister GK, Hackett LP, Duffull SB. The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach. J Pharmacokinet Pharmacodyn 2005; 32:571–605.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Friberg LE, Hackett LP, Duffull SB. Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal. Clin Pharmacol Ther 2007; 81:821–827.
   PubMed Web of Science ®Google Scholar
• Kumar VV, Oscarsson S, Friberg LE, Isbister GK, Hackett LP, Duffull SB. The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdose. Clin Pharmacol Ther 2009; 86:403–410.
   PubMed Web of Science ®Google Scholar
• Beal SL. Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn 2001; 28:481–504.
   PubMed Web of Science ®Google Scholar
• Wings for NONMEM. http://wfn.sourceforge.net/Accessed 30 June 2010.
   Google Scholar
• Urien S. Wings for NONMEM. RFN-831-20070911. http://sourceforge.net/project/showfiles.php?group_id=29501&package_id=140129 &release_id = 538680 Accessed 30 June 2010.
   Google Scholar
• Bland JM, Altman DG. Statistical method for assessing agreement between two methods of clinical measurement. The Lancet 1986; i:307–310.
   Web of Science ®Google Scholar
• Mager D, Wyska E, Jusko W. Diversity of mechanism-based pharmacodynamic models. Drug Metab Dispos 2003; 31:510–518.
   PubMed Web of Science ®Google Scholar
• Angel G, Guerre Berthelot P, Rogier C. Hypokalaemia related to acute chloroquine poisoning. Lancet 1995; 346:1625.
   PubMed Web of Science ®Google Scholar
• Clemessy JL, Favier C, Borron SW, Hantson PE, Vicaut E, Baud FJ. Hypokalaemia related to acute chloroquine ingestion. Lancet 1995; 346:877–880.
   PubMed Web of Science ®Google Scholar
• Ducharme J, Farinotti F. Clinical Pharmacokinetics and metabolism of chloroquine. Clin Pharmacokinet 1996; 31:257–274.
   PubMed Web of Science ®Google Scholar
• Krishna S, White NJ. Pharmacokinetics of quinine, chloroquine and amiodaquine. Clin Pharmacokinet 1996; 30:263–299.
   PubMed Web of Science ®Google Scholar
• Frisk-Holmberg M, Bergqvist Y, Termond E, Domeij-Nyberg B. The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. Eur J Clin Pharmacol 1984; 26:521–530.
   PubMed Web of Science ®Google Scholar
• McChesney EW, Fasco MJ, Banks WF Jr. The metabolism of chloroquine in man during and after repeated oral dosage. J Pharmacol Exp Ther 1967; 158:323–331.
   PubMed Web of Science ®Google Scholar
• Projean D, Baune B, Farinotti R, Flinois JP, Beaune P, Taburet AM, Ducharme J. In vitro metabolism of chloroquine: identification of CYP 2C8, CYP 3A4 and CYP 2D6 as the main isoforms catalyzing N-desethylchloroquine formation. Drug Metab Dispos 2003; 31:748–754.
   PubMed Web of Science ®Google Scholar
• Hellgren U, Alván G, Jerling M. On the question of interindividual variations in chloroquine concentrations. Eur J Clin Pharmacol 1993; 45:383–385.
   PubMed Web of Science ®Google Scholar
• Augustijns P, Geusens P, Verbeke N. Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis. Eur J Clin Pharmacol 1992; 44:407–410.
   Google Scholar
• Gustafsson LL, Walker O, Alván G, Beermann B, Estevez F, Gleisner L, Lindström B, Sjöqvist F. Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol 1983; 15:471–479.
   PubMed Web of Science ®Google Scholar
• Rengelshausen J, Burhenne J, Fröhlich M, Tayrouz Y, Singh SK, Riedel KD, Müller O, Hoppe-Tichy T, Haefeli WE, Mikus G, Walter-Sack I. Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria. Eur J Clin Pharmacol 2004; 60:709–715.
   PubMed Web of Science ®Google Scholar
• Tett SE, Cutler DJ, Day RO, Brown KF. A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers. Br J Clin Pharmacol 1988; 26:303–313.
   PubMedGoogle Scholar
• Dua VK, Gupta NC, Kar PK, Nand J, Edwards G, Sharma VP, Subbarao SK. Chloroquine and desethylchloroquine concentrations in blood cells and plasma from Indian patients infected with sensitive or resistant Plasmodium falciparum. Ann Trop Med Parasitol 2000; 94:565–570.
   PubMed Web of Science ®Google Scholar
• Adelusi SA, Dawodu AH, Salako LA. Kinetics of the uptake and elimination of chloroquine in children with malaria. Br J Clin Pharmacol 1982; 14:483–487.
   PubMed Web of Science ®Google Scholar
• Boereboom FT, Ververs FF, Meulenbelt J, van Dijk A. Hemoperfusion is ineffectual in severe chloroquine poisoning. Crit Care Med 2000; 28:3346–3350.
   PubMed Web of Science ®Google Scholar
• Nosál R, Ericsson O, Sjöqvist F. Distribution of chloroquine in human blood fractions. Methods Find Exp Clin Pharmacol 1988; 10:581–587.
   PubMed Web of Science ®Google Scholar
• Bergqvist Y, Domeij-Nyberg B. Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. J Chromatogr 1983; 272:137–148.
   PubMed Web of Science ®Google Scholar
• Mégarbane B, Aslani AA, Deye N, Baud FJ. Pharmacokinetic/pharmacodynamic modeling of cardiac toxicity in human acute overdoses: utility and limitations. Expert Opin Drug Metab Toxicol 2008; 4:569–579.
   PubMed Web of Science ®Google Scholar
• Baud FJ. Pharmacokinetic-pharmacodynamic relationships. How are they useful in human toxicology? Toxicol Lett 1998; 102–103: 643–648.
   PubMed Web of Science ®Google Scholar
• Hellgren U, Kihamia CM, Mahikwano LF, Björkman A, Eriksson O, Rombo L. Response of Plasmodium falciparum to chloroquine treatment: relation to whole blood concentrations of chloroquine and desethylchloroquine. Bull World Health Organ 1989; 67:197–202.
   PubMed Web of Science ®Google Scholar
• Ekland EH, Fidock DA. Advances in understanding the genetic basis of antimalarial drug resistance. Curr Opin Microbiol 2007; 10:363–370.
   PubMed Web of Science ®Google Scholar
• Geary TG, Akood MA, Jensen JB. Characteristics of chloroquine binding to glass and plastic. Am J Trop Med Hyg 1983; 32:19–23.
   PubMed Web of Science ®Google Scholar
• Malmgren R, Olsson P, Unge G. The effect of various inhibitors on the 5-HT binding and uptake by human platelets. Thromb Res 1981; 22:469–480.
   PubMed Web of Science ®Google Scholar
• Na-Bangchang K, Limpaibul L, Thanavibul A, Tan-Ariya P, Karbwang J. The pharmacokinetics of chloroquine in healthy Thai subjects and patients with Plasmodium vivax malaria. Br J Clin Pharmacol 1994; 38:278–281.
   PubMed Web of Science ®Google Scholar
• Ciszowski K, Winnik L, Groszek B, Klys M, Kolodziej J. Acute chloroquine intoxication – rare, but always serious: case reports and literature review. Przegl Lek 2005; 62:501–507.
   PubMedGoogle Scholar
• Reddy VG, Sinna S. Chloroquine poisoning: report of two cases. Acta Anaesthesiol Scand 2000; 44:1017–1020.
   PubMed Web of Science ®Google Scholar
• Bergqvist Y, Englund U. Pharmacokinetics in chloroquine overdosage. Lakartidningen 1983; 80:348–349.
   PubMedGoogle Scholar
• Jordan P, Brookes JG, Nikolic G, Le Couteur DG. Hydroxychloroquine overdose: toxicokinetics and management. J Toxicol Clin Toxicol 1999; 37:861–864.
   PubMed Web of Science ®Google Scholar
• McLachlan A, Tett S, Day R. Interpretation of chloroquine pharmacokinetic data. Eur J Clin Pharmacol 1993; 44:407–410.
   PubMed Web of Science ®Google Scholar
• Tett SE, Cutler DJ. Apparent dose-dependence of chloroquine pharmacokinetics due to limited assay sensitivity and short sampling times. Eur J Clin Pharmacol 1987; 31:729–731.
   PubMed Web of Science ®Google Scholar